成人重症哮喘长期口服糖皮质激素治疗的后果及其副作用:文献影响数据的聚焦综述
本综述基于MEDLINE、Embase和Cochrane Library的系统文献检索,概述了成人重症哮喘长期口服糖皮质激素(OCS)治疗的作用及其相关副作用。研究显示,与对照组相比,长期暴露于OCS的重症哮喘患者发生感染、糖尿病、骨质疏松及精神障碍等并发症的风险更高,且医疗资源使用显著增加。因此,临床医生在处方长期OCS治疗前需仔细权衡防止哮喘失控的潜在获益与上述风险,并应采用有效的保皮质类固醇策略,以最低有效剂量短期使用并尽快减停。
要点
- 长期OCS治疗增加重症哮喘患者感染、糖尿病、骨质疏松及精神障碍风险。
- 长期OCS治疗显著增加医疗资源使用。
- 处方长期OCS前需权衡防止哮喘失控的获益与风险,并采用保皮质类固醇策略。
核心结论
- 长期口服糖皮质激素治疗重症哮喘患者发生感染、糖尿病、骨质疏松及精神障碍等并发症的风险高于对照组,且医疗资源使用显著增加。
- 临床医生在处方长期OCS前应仔细权衡防止哮喘失控的潜在获益与风险,并采用有效的保皮质类固醇策略。
研究设计与样本
- 聚焦综述,基于MEDLINE、Embase和Cochrane Library的系统文献检索。
主要发现
- 在OCS治疗的哮喘患者中呈现剂量-反应关系。
- 长期暴露于OCS的重症哮喘患者发生感染、糖尿病、骨质疏松及精神障碍等并发症的风险高于对照组。
- OCS治疗导致医疗资源使用显著增加。
临床怎么用
- 处方长期OCS前需权衡防止哮喘失控的获益与风险。
- 采用有效的保皮质类固醇策略,目标为短期使用、最低有效剂量并尽快减停直至终止OCS治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This review provides an overview of the role of long-term treatment of severe asthma with oral corticosteroids (OCS) and its associated side-effects in adults. It is based on a systematic literature search conducted in MEDLINE, Embase and the Cochrane Library to identify relevant studies. After a short overview of severe asthma and its treatment we present studies showing a dose-response relationship in asthmatic patients treated with OCS and then consider by organ systems the undesired effects demonstrated in clinical and epidemiological studies in patients with OCS-dependent asthma. It was found that the risk of developing various OCS-related complications, including infections, diabetes and osteoporosis as well as psychiatric disorders, was higher for patients with long-term exposure to OCS compared with control groups. In addition, studies showed a significant increase in healthcare resource utilisation due to OCS treatment. Therefore, it is incumbent on every clinician to carefully weigh the potential benefit of preventing loss of asthma control against this risk before opting to prescribe long-term OCS therapy. Effective corticosteroid-sparing strategies must be used and should aim at short-term use with the lowest effective dose and start tapering as soon as possible until OCS therapy is terminated.
引用
- Volmer T, Effenberger T, Trautner C, et al. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018. PMID: 30190274. doi:10.1183/13993003.00703-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。